Allurion Technologies (ALUR) Competitors $3.60 +1.32 (+57.72%) Closing price 03/21/2025 03:58 PM EasternExtended Trading$3.58 -0.02 (-0.42%) As of 03/21/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALUR vs. SPAI, APYX, BDMD, DXR, CLGN, FEMY, MODD, POCI, NMTC, and MDAIShould you be buying Allurion Technologies stock or one of its competitors? The main competitors of Allurion Technologies include Safe Pro Group Inc. Common Stock (SPAI), Apyx Medical (APYX), Baird Medical Investment (BDMD), Daxor (DXR), CollPlant Biotechnologies (CLGN), Femasys (FEMY), Modular Medical (MODD), Precision Optics (POCI), NeuroOne Medical Technologies (NMTC), and Spectral AI (MDAI). These companies are all part of the "medical equipment" industry. Allurion Technologies vs. Safe Pro Group Inc. Common Stock Apyx Medical Baird Medical Investment Daxor CollPlant Biotechnologies Femasys Modular Medical Precision Optics NeuroOne Medical Technologies Spectral AI Allurion Technologies (NYSE:ALUR) and Safe Pro Group Inc. Common Stock (NASDAQ:SPAI) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, valuation, analyst recommendations, media sentiment, earnings, profitability, risk and dividends. Does the MarketBeat Community favor ALUR or SPAI? Allurion Technologies received 8 more outperform votes than Safe Pro Group Inc. Common Stock when rated by MarketBeat users. CompanyUnderperformOutperformAllurion TechnologiesOutperform Votes880.00% Underperform Votes220.00% Safe Pro Group Inc. Common StockN/AN/A Do analysts recommend ALUR or SPAI? Allurion Technologies currently has a consensus price target of $22.83, suggesting a potential upside of 534.96%. Given Allurion Technologies' stronger consensus rating and higher probable upside, research analysts clearly believe Allurion Technologies is more favorable than Safe Pro Group Inc. Common Stock.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Allurion Technologies 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00Safe Pro Group Inc. Common Stock 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is ALUR or SPAI more profitable? Safe Pro Group Inc. Common Stock has a net margin of 0.00% compared to Allurion Technologies' net margin of -71.24%. Company Net Margins Return on Equity Return on Assets Allurion Technologies-71.24% N/A -56.75% Safe Pro Group Inc. Common Stock N/A N/A N/A Does the media prefer ALUR or SPAI? In the previous week, Allurion Technologies had 10 more articles in the media than Safe Pro Group Inc. Common Stock. MarketBeat recorded 11 mentions for Allurion Technologies and 1 mentions for Safe Pro Group Inc. Common Stock. Safe Pro Group Inc. Common Stock's average media sentiment score of 0.95 beat Allurion Technologies' score of 0.08 indicating that Safe Pro Group Inc. Common Stock is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Allurion Technologies 1 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Safe Pro Group Inc. Common Stock 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals believe in ALUR or SPAI? 21.4% of Allurion Technologies shares are owned by institutional investors. 22.4% of Allurion Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has preferable earnings & valuation, ALUR or SPAI? Safe Pro Group Inc. Common Stock has lower revenue, but higher earnings than Allurion Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAllurion Technologies$34.75M0.50-$80.61M-$12.00-0.30Safe Pro Group Inc. Common Stock$1.56M25.77N/AN/AN/A SummaryAllurion Technologies beats Safe Pro Group Inc. Common Stock on 9 of the 13 factors compared between the two stocks. Remove Ads Get Allurion Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ALUR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALUR vs. The Competition Export to ExcelMetricAllurion TechnologiesSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$17.24M$4.44B$5.73B$19.55BDividend YieldN/A29.35%4.39%3.75%P/E Ratio-0.3029.5024.7933.49Price / Sales0.5050.44398.2428.58Price / CashN/A51.0838.1617.54Price / Book-0.106.237.114.56Net Income-$80.61M$67.64M$3.20B$1.02B7 Day Performance39.43%8.94%0.77%-0.36%1 Month Performance6.39%-1.34%3.66%-3.42%1 Year Performance-92.22%23.73%14.64%5.93% Allurion Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALURAllurion Technologies2.945 of 5 stars$3.60+57.7%$22.83+535.0%-92.2%$17.24M$34.75M-0.30501Upcoming EarningsAnalyst ForecastNews CoverageGap UpHigh Trading VolumeSPAISafe Pro Group Inc. Common StockN/A$3.20-1.2%N/AN/A$44.03M$1.56M0.0011Positive NewsAPYXApyx Medical1.3927 of 5 stars$1.13+13.0%N/A+0.8%$42.54M$48.54M-1.36270Gap UpBDMDBaird Medical InvestmentN/A$5.97-1.6%N/AN/A$39.31M$33.05M0.00N/ADXRDaxor4.1207 of 5 stars$7.97-2.6%$25.00+213.7%+0.2%$38.55M$2.13M0.0037Positive NewsGap UpCLGNCollPlant Biotechnologies2.2573 of 5 stars$3.30+0.8%$12.50+279.2%-36.6%$37.76M$650,000.00-2.1470Positive NewsGap DownFEMYFemasys2.6342 of 5 stars$1.60+1.9%$10.00+525.0%-3.6%$36.64M$1.26M-1.9830Upcoming EarningsAnalyst RevisionMODDModular Medical0.5255 of 5 stars$0.87-2.9%$5.00+472.5%-41.5%$35.51MN/A-1.6520Gap UpPOCIPrecision Optics0.3576 of 5 stars$4.53+0.7%N/A-20.5%$34.60M$18.68M-7.0880Positive NewsNMTCNeuroOne Medical Technologies0.0618 of 5 stars$1.08flatN/A-12.7%$33.33M$5.75M-4.1520MDAISpectral AI2.3421 of 5 stars$1.76+13.5%$4.75+169.9%-27.4%$32.72M$27.26M-2.7183Upcoming Earnings Remove Ads Related Companies and Tools Related Companies Safe Pro Group Inc. Common Stock Competitors Apyx Medical Competitors Baird Medical Investment Competitors Daxor Competitors CollPlant Biotechnologies Competitors Femasys Competitors Modular Medical Competitors Precision Optics Competitors NeuroOne Medical Technologies Competitors Spectral AI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ALUR) was last updated on 3/24/2025 by MarketBeat.com Staff From Our PartnersElon Musk’s NEW Project… RevealedYou won't believe what Elon Musk is hiding… Inside this facility in the middle of an industrial zone of Memphi...InvestorPlace | SponsoredTrump Shock to change everything Is this Trump’s next major move? Millionaire trading expert Imre Gams has found a bill that directs the Uni...Centurion Publishing | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredHere’s Why Tesla Insiders are Dumping SharesTesla has been on a losing streak ever since Elon Musk first visited the White House in early 2025. Our res...Behind the Markets | SponsoredThis Crypto Is Set to Explode in FebruaryBryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allurion Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allurion Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.